These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16294365

  • 41. [Description of type 2 diabetes mellitus in residents of Ile-de-France aged at most 70 years].
    Silvera L, Simon D, Trutt B, Blanchon B, Parmentier M, Hecquard P.
    Diabetes Metab; 2000 Sep; 26 Suppl 6():69-76. PubMed ID: 11011242
    [Abstract] [Full Text] [Related]

  • 42. [Drug prescriptions and demographic indicators in a diabetic population in Argentina].
    Quaglia NB, Nuñez MH, Marzi MM.
    Farm Hosp; 2012 Sep; 36(2):92-6. PubMed ID: 22047667
    [Abstract] [Full Text] [Related]

  • 43. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study.
    Lawton J, Ahmad N, Hallowell N, Hanna L, Douglas M.
    BMJ; 2005 May 28; 330(7502):1247. PubMed ID: 15883139
    [Abstract] [Full Text] [Related]

  • 44. [Health behaviors in Portugal. Epidemiological studies].
    do Carmo I.
    Acta Med Port; 1997 May 28; 10(6-7):433-45. PubMed ID: 9341035
    [Abstract] [Full Text] [Related]

  • 45. Theoretical exposure of chronically treated patients to lipid lowering agents.
    Kucera Z, Vlcek J, Hejdova M.
    Pharmacoepidemiol Drug Saf; 2005 Jan 28; 14(1):61-7. PubMed ID: 15508131
    [Abstract] [Full Text] [Related]

  • 46. Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences.
    Simon-Tuval T, Shmueli A, Harman-Boehm I.
    Curr Med Res Opin; 2018 Feb 28; 34(2):345-351. PubMed ID: 29069921
    [Abstract] [Full Text] [Related]

  • 47. [Individual-based statistics on drug utilization].
    Hallas J, Nissen A.
    Ugeskr Laeger; 1996 Jan 01; 158(1):41-6. PubMed ID: 8560623
    [Abstract] [Full Text] [Related]

  • 48. [Clinical and therapeutic analysis of type 2 diabetics in Portuguese community pharmacies].
    Pires C.
    Acta Med Port; 2011 Dec 01; 24 Suppl 2():449-56. PubMed ID: 22849934
    [Abstract] [Full Text] [Related]

  • 49. Quality of life and patient-perceived difficulties in the treatment of type 2 diabetes.
    Tamir O, Wainstein J, Raz I, Shemer J, Heymann A.
    Rev Diabet Stud; 2012 Dec 01; 9(1):46-54. PubMed ID: 22972444
    [Abstract] [Full Text] [Related]

  • 50. [Antidiabetic drugs and in-patient admissions attributable to diabetes in Portugal].
    Gouveia M, Laires P, Borges M, Augusto M, Martins AP.
    Acta Med Port; 2012 Dec 01; 25(5):323-31. PubMed ID: 23211204
    [Abstract] [Full Text] [Related]

  • 51. Pharmacoepidemiological profiles of oral hypoglycemic agents among 28,773 Chinese patients with diabetes.
    Wong MC, Kong AP, So WY, Tse SL, Wang HH, Jiang JY, Chan JC, Griffiths SM.
    Diabetes Res Clin Pract; 2012 Jun 01; 96(3):319-25. PubMed ID: 22305941
    [Abstract] [Full Text] [Related]

  • 52. Drug utilization studies and epidemiology.
    Tognoni G, Liberati A, Pellò L, Sasanelli F, Spagnoli A.
    Rev Epidemiol Sante Publique; 1983 Jun 01; 31(1):59-71. PubMed ID: 6856922
    [Abstract] [Full Text] [Related]

  • 53. [How many diabetic patients are there in France?].
    Passa P.
    Diabetes Metab; 1999 Sep 01; 25(4):366-7. PubMed ID: 10566129
    [No Abstract] [Full Text] [Related]

  • 54. Prevalence of drug-treated diabetes mellitus in Belgium. Results of a study with the collaboration of a network of pharmacies.
    Walckiers D, Van der Veken J, Papoz L, Stroobant A.
    Eur J Clin Pharmacol; 1992 Sep 01; 43(6):613-9. PubMed ID: 1493842
    [Abstract] [Full Text] [Related]

  • 55. Utilization of oral antihyperglycemic drugs over a 7-year period (1998-2004) in a Hungarian population and adherence to drug therapy.
    Doró P, Benko R, Kosik E, Matuz M, Tóth K, Soós G.
    Eur J Clin Pharmacol; 2005 Dec 01; 61(12):893-7. PubMed ID: 16328320
    [Abstract] [Full Text] [Related]

  • 56. Epidemiology in Malta from routine health information.
    Schranz AG.
    Diabetes Res Clin Pract; 1994 May 01; 24(1):41-6. PubMed ID: 7924885
    [Abstract] [Full Text] [Related]

  • 57. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database.
    Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W.
    Lancet; 2003 Aug 16; 362(9383):537-8. PubMed ID: 12932388
    [Abstract] [Full Text] [Related]

  • 58. Types of diabetes treatment in a total, Norwegian, adult population. The Nord-Trøndelag Diabetes Study.
    Midthjell K, Holmen J, Bjørndal A.
    J Intern Med; 1994 Sep 16; 236(3):255-61. PubMed ID: 8077880
    [Abstract] [Full Text] [Related]

  • 59. [Prognosis for insulin requirements in Czechoslovakia].
    Hauser F, Andĕl M, Honzáková L, Stika L.
    Cas Lek Cesk; 1989 Oct 27; 128(43-44):1345-9. PubMed ID: 2688893
    [Abstract] [Full Text] [Related]

  • 60. Controversy of oral hypoglycemic agents in type 2 diabetes mellitus: Novel move towards combination therapies.
    Ghadge AA, Kuvalekar AA.
    Diabetes Metab Syndr; 2017 Nov 27; 11 Suppl 1():S5-S13. PubMed ID: 27578618
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.